vancomycin has been researched along with penicillanic acid in 113 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (7.08) | 18.2507 |
| 2000's | 17 (15.04) | 29.6817 |
| 2010's | 70 (61.95) | 24.3611 |
| 2020's | 18 (15.93) | 2.80 |
| Authors | Studies |
|---|---|
| Betschel, S; Kreiswirth, B; Low, DE; Willey, BM | 1 |
| Kinzig, M; Sörgel, F | 1 |
| Atwood, E; DiTore, V; Landman, D; Patel, K; Quale, J; Saurina, G | 1 |
| Palmer, SM; Rybak, MJ | 1 |
| Fraser, SL; Jorgensen, JH | 1 |
| Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
| Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P | 1 |
| Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I | 1 |
| Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW | 1 |
| Baddour, LM; Googe, PB; Prince, TL | 1 |
| Chua, A; Jimenez, VE; Tortora, G; Younus, F | 1 |
| Beilman, GJ; Feltis, BA; Lee, DA | 1 |
| Akan, H; Calandra, T; Cometta, A; Crokaert, F; De Bock, R; Engelhard, D; Gaya, H; Glauser, MP; Kern, WV; Klastersky, J; Korten, V; Marchetti, O; Padmos, A; Paesmans, M; Skoutelis, A; Vandenbergh, M; Vandercam, M; Viscoli, C; Zinner, S | 1 |
| Chin, NX; Della-Latta, P; Libre, PE | 1 |
| Glasmacher, A; Wade, JC | 1 |
| Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM | 1 |
| Boghossian, J; Caputo, W; Dana, A; Gray, S; Harkless, L; Pollak, R; Wu, D | 1 |
| Carmeli, Y; Flores, EL; Lin, MY; Sreeramoju, P; Tolentino, J; Weber, SG; Zumsteg, J | 1 |
| Howell, JM; Mohammadi, A | 1 |
| Hoda, MQ; Hussein, K; Manasia, R; Salahuddin, N; Samad, A; Siddiqui, S; Zafar, A | 1 |
| Aronowitz, P; London, V | 1 |
| MacDougall, C; Oinonen, M; Pakyz, AL; Polk, RE | 1 |
| Al Hassan, M; Byrd, RP; Halawa, A; Roy, TM; Yacoub, G | 1 |
| Akinci, E; Balaban, N; Baran, G; Bodur, H; Cevik, MA; Erbay, A; Onguru, P | 1 |
| Chun, ED; Collins, CD; Malani, PN; Rodgers, PE; Vitale, CA | 1 |
| Foley, RJ; Kannan, S; Kourelis, T | 1 |
| Bansal, D; Gautam, V; Marwaha, N; Marwaha, RK; Oberoi, S; Sharma, RR | 1 |
| Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH | 1 |
| Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
| Jawitz, RS; Krach, K; Schapiro, B | 1 |
| Holodniy, M; Lucero, CA; Mercier, RC; Nguyen, N; Oda, G; Ryono, RA; Schirmer, PL | 1 |
| Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E | 1 |
| Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS | 1 |
| Fett, N; Kovarik, CL; Wanat, KA | 1 |
| Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
| Adamson, RT; Amara, S; Huang, X; Lew, I | 1 |
| Leung, E; Ly, SC; Scheetz, MH; Venkatesan, N | 1 |
| Finnegan, PM; Hand, S; Linneman, TW; McDonald, JR; Moenster, RP; Thomas, Z | 1 |
| Dilworth, TJ; Dodd, M; Mercier, RC; Ryan, K; Sliwinski, J | 1 |
| Fortier, LC; Garneau, JR; Valiquette, L | 1 |
| Feng, X; He, L; He, Y; Li, C; Liu, H; Liu, X; Ruan, Y; Wu, X; Zhang, Y | 1 |
| Birch, A; Della Vecchia, BJ; Dupree, L; Gomes, DM; Jankowski, CA; Kraemer, DF; Smotherman, C | 1 |
| Burgess, LD; Drew, RH | 1 |
| Dilworth, TJ; Leonard, SN; Mercier, RC; Vilay, AM | 1 |
| Chen, PL; Hung, YP; Ko, WC; Lee, JC; Lin, HJ; Liu, HC; Tsai, PJ; Wu, CJ; Wu, YH; Yeh, FH | 1 |
| Agudelo, M; Gonzalez, JM; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Joundi, RA; Leis, JA; Wong, BM | 1 |
| Baines, C; Brown, B; Lewis, I; Smart, D | 1 |
| Cury, JD; Dakkak, M; Siddiqi, F | 1 |
| Bose, S; Popovich, MJ; Silver, BJ; Wurm, E | 1 |
| Listernick, R | 1 |
| Anderson, AM; Easley, K; Kandiah, S; Kim, T; Patel, M; Rab, S; Wong, J; Xue, W | 1 |
| Davies, SW; Dietch, ZC; Efird, JT; Guidry, CA; Sawyer, RG; Shah, PM; Willis, RN | 1 |
| El-Ibiary, S; Gorlitsky, B | 1 |
| Fodero, KE; Horey, AL; Krajewski, MP; Mergenhagen, KA; Ruh, CA; Sellick, JA | 1 |
| Manek, M; O'Donnell, JN; Rhodes, NJ; Scheetz, MH; Venkatesan, N | 1 |
| Cohen, H; Peyko, V; Smalley, S | 1 |
| Hammond, DA; Lusardi, K; Meena, NK; Painter, JT; Smith, MN | 1 |
| Karino, S; Kaye, KS; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
| Carroll, K; Romagnoli, M; Simner, PJ; Wang, F; Workneh, M | 1 |
| Abraham, MK; Crouter, AJ; Wilkerson, RG | 1 |
| Ahrens, CL; Bauer, SR; Bollinger, JE; Harinstein, LM; Petite, SE | 1 |
| Mellen, CK; Rindone, JP; Ryba, JE | 1 |
| Giuliano, CA; Kale-Pradhan, PB; Patel, CR | 1 |
| Burgess, DR; Burgess, DS; Cox, JN; Martin, CA; Rutter, WC | 1 |
| Beardsley, J; Johnson, J; Liu, P; Luther, V; Ohl, C; Williamson, J | 1 |
| Evans, R; Hussain, T; Karino, S; Kaye, KS; Koons, J; Koppula, S; Martin, ET; Murray, KP; Mynatt, RP; Navalkele, B; Nishan, B; Perry, W; Pervaiz, A; Pogue, JM; Rybak, MJ; Salim, M; Shaikh, H; Solanki, S; Tashtoush, N | 1 |
| Cai, Y; Haddad, J; Saqi, A | 1 |
| Compain, F; Guerot, E; Jarraud, S; Podglajen, I; Richaud, C; Rossi, B; Rostane, H | 1 |
| Dubrovskaya, Y; Louie, E; Mousavi, M; Papadopoulos, J; Scipione, MR; Zapolskaya, T | 1 |
| Burgess, DR; Burgess, DS; Rutter, WC; Talbert, JC | 1 |
| Burgess, DS; Rutter, WC | 1 |
| Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
| LeCleir, LK; Pettit, RS | 1 |
| Farber, JL; Filippone, EJ; Kraft, WK | 1 |
| Hincapie Castillo, J; Jeon, N; Klinker, KP; Staley, B; Winterstein, AG | 1 |
| Effraim, P; Li, L; Tham, SW; Waxman, S | 1 |
| Anderson, CW; Cazares, KS; Denunzio, TM; Lustik, MB; Patel, SM | 1 |
| Fusco, NM; Hassinger, AB; Holsen, MR; Meaney, CJ | 1 |
| Awdishu, L | 1 |
| Bryan, M; Cowden, C; Downes, KJ; Fisher, BT; Goldstein, SL; Gong, W; Huang, YS; Laskin, BL; Zaoutis, TE | 1 |
| Deresinski, S; Watkins, RR | 1 |
| Kempker, RR; Kumar, S; Mgbemena, O; Serota, DP; Weiss, DS; Wozniak, JE | 1 |
| Caffrey, AR; Dosa, D; LaPlante, KL; Lodise, TP; Luther, MK; Timbrook, TT | 1 |
| Abouelkheir, M; Alsubaie, S | 1 |
| Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
| Adondakis, MG; Brown, EM; Oliver, MR; Skedros, JG | 1 |
| Jaffer, ZN; Nicholson, C | 1 |
| Jafri, SM; Nemakayala, DR; Rai, MP; Rayamajhi, S | 1 |
| Arıcı, M; Balcı, C; Hayran, SA; Ünal, S; Uzun, Ö; Yüce, D | 1 |
| Asano, T; Hirano, S; Imai, S; Kushiya, H; Miyasaka, D; Nakamura, T; Nakanishi, Y; Noji, T; Okamura, K; Shichinohe, T; Tanaka, K; Tsuchikawa, T | 1 |
| Gopalakrishnan, M; John, JF; Manappallil, RG; Nambiar, H | 1 |
| Leong, D; Wu, PE | 1 |
| Bergstrom, C; Gupta, A; Nagalla, S | 1 |
| Juang, P; Kollef, MH; Micek, ST | 1 |
| Avedissian, SN; Liu, J; Pais, GM; Rhodes, NJ; Scheetz, MH | 1 |
| Avedissian, SN; Chalkias, A; d'Aloja, E; Downes, KJ; Fitzgerald, JC; Gilchrist, A; Hiner, D; Liu, J; Locci, E; Lodise, TP; Pais, GM; Prozialeck, WC; Rhodes, NJ; Scheetz, MH; Xanthos, T; Zuppa, AF | 1 |
| Becker, A; Braun, E; Chaudier, P; Chidiac, C; Corbin, K; Dupieux, C; Ferry, T; Fessy, MH; Goutelle, S; Gunst, S; Laurent, F; Lustig, S; Mabrut, E; Triffault-Fillit, C; Valour, F | 1 |
| DeMott, JM; Hammond, DA; Peksa, GD; Traversa, A | 1 |
| Brüggemann, RJ; de Wildt, SN; Kolwijck, E; Kramers, C; Schouten, JA; Workum, JD | 1 |
| Imai, T; Kakeya, H; Kawaguchi, H; Nagayama, K; Nakamura, Y; Oshima, K; Sakurai, N; Shibata, W; Yamada, K; Yamashita, Y; Yano, T | 1 |
| Dote, S; Horiuchi, N; Inose, R; Kobayashi, Y; Muraki, Y; Sazanami, K; Yagi, T | 1 |
| Aizawa, F; Azuma, M; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izumi, Y; Nakamoto, A; Okada, N; Yagi, K; Zamami, Y | 1 |
| Agarwal, SK; Buckley, MS; D'Alessio, PA; Kane-Gill, SL; Kobic, E; Komerdelj, IA; Martinez, BK; Rangan, P; Tinta, NC; Yerondopoulos, MJ; Ziadat, DS | 1 |
| Al-Jebawi, Y; Karalic, K; Mhanna, MJ; Shekhawat, P | 1 |
| Agyekum, RS; Anderson, BJ; Cosgriff, CV; Dunn, TG; Giannini, HM; Hennessy, S; Ittner, CAG; Jones, TK; Meyer, NJ; Miano, TA; Oniyide, O; Reilly, JP; Shashaty, MGS; Townsend, R; Turner, AP; Weisman, AR; Wilson, FP; Yang, W | 1 |
| Bian, L; He, K; Liang, W; Lv, J; Wu, Z; Yue, H | 1 |
| Côté, JM; Kane-Gill, SL; Murray, PT | 1 |
| Carta, N; Décaudin, B; Degand, F; Gaudy, R; Genay, S; Lebuffe, G; Martin Mena, A; Maury, É; Négrier, L; Odou, P; Thibaut, M | 1 |
| Caldwell, JT; Dong, S; Fei, L; Goldstein, SL; Hasson, D; Kaplan, J; Slagle, C; Tang Girdwood, S; Tang, P; Vinks, AA | 1 |
| Furuya, K; Ito, K; Makio, S; Shimada, T; Sugiyama, K | 1 |
| Barreto, EF; Chang, J; Lesnicki, E; Marianski, S; Pais, GM; Scheetz, MH; Valdez, K | 1 |
8 review(s) available for vancomycin and penicillanic acid
| Article | Year |
|---|---|
Enterococcis: pathogens of the 90s.
Topics: Abdominal Abscess; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1994 |
Pharmacokinetic characteristics of piperacillin/tazobactam.
Topics: beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors; Tissue Distribution; Tobramycin; Vancomycin | 1994 |
Mycotic aneurysm of the descending thoracic aorta caused by Pseudomonas aeruginosa in a solid organ transplant recipient: case report and review.
Topics: Adult; Aneurysm, Infected; Aortic Aneurysm, Thoracic; Aztreonam; Blood Vessel Prosthesis Implantation; Debridement; Drug Therapy, Combination; Humans; Infusions, Parenteral; Male; Organ Transplantation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Secondary Prevention; Treatment Outcome; Vancomycin | 2002 |
Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kidney Diseases; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Vancomycin | 2017 |
Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2016 |
The Nephrotoxicity of Vancomycin.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Vancomycin | 2017 |
Drug-induced kidney disease in the ICU: mechanisms, susceptibility, diagnosis and management strategies.
Topics: Acute Kidney Injury; Critical Illness; Disease Susceptibility; Drug Therapy, Combination; Humans; Intensive Care Units; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Renal Replacement Therapy; Risk Factors; Vancomycin | 2017 |
Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis.
Topics: Acute Kidney Injury; Adult; Critical Care; Drug Therapy, Combination; Humans; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic; Vancomycin | 2018 |
7 trial(s) available for vancomycin and penicillanic acid
| Article | Year |
|---|---|
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1998 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin | 1999 |
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Fever; Humans; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2003 |
Vancomycin does not benefit persistently febrile neutropenic people with cancer.
Topics: Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Fever; Follow-Up Studies; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome; Vancomycin | 2004 |
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Diabetic Foot; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sulbactam; Time Factors; Vancomycin; Wound Infection | 2005 |
Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia.
Topics: Adolescent; Agranulocytosis; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infection Control; Length of Stay; Leukemia, Myeloid, Acute; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin | 2014 |
98 other study(ies) available for vancomycin and penicillanic acid
| Article | Year |
|---|---|
Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci.
Topics: Ampicillin; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Vancomycin | 1996 |
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin
Topics: Ampicillin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fibrin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Sulbactam; Tazobactam; Vancomycin | 1997 |
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Flavobacterium; Fluoroquinolones; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Reproducibility of Results; Vancomycin | 1997 |
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin | 2000 |
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries | 2000 |
Possible role of cellular immunity: a case of cellulitis.
Topics: Cellulitis; Clindamycin; Drug Eruptions; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypersensitivity, Delayed; Middle Aged; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Vancomycin | 2001 |
Lemierre's disease caused by co-infection of Arcanobacterium haemolyticum and Fusobacterium necrophorum: a case report.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Fusobacterium Infections; Humans; Jugular Veins; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thrombophlebitis; Vancomycin | 2002 |
Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model.
Topics: Anti-Bacterial Agents; Endophthalmitis; Enzyme Inhibitors; Eye; Half-Life; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin | 2003 |
Cervical spondylodiscitis from an ingested pin: a case report.
Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating | 2005 |
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
Topics: Anti-Infective Agents; Candida glabrata; Candidiasis; Case-Control Studies; Cross Infection; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin | 2005 |
Sternal tuberculosis.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections; Mycobacterium tuberculosis; Ofloxacin; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sternum; Thorax; Tomography, X-Ray Computed; Tuberculosis; Vancomycin | 2009 |
Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Developing Countries; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization Review; Humans; Imipenem; Intensive Care Units; Medical Order Entry Systems; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Program Development; Vancomycin | 2007 |
Purpuric rash of meningococcemia.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Bacteremia; Ceftriaxone; Humans; Hydrocortisone; Male; Meningococcal Infections; Middle Aged; Neisseria meningitidis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein C; Purpura; Recombinant Proteins; Vancomycin | 2008 |
Trends in antibacterial use in US academic health centers: 2002 to 2006.
Topics: Academic Medical Centers; Adult; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; United States; Vancomycin | 2008 |
Dacryocystitis: an unusual form of Mucorales infection.
Topics: Adult; Anti-Bacterial Agents; Dacryocystitis; Enzyme Inhibitors; Female; Humans; Mucorales; Mucormycosis; Penicillanic Acid; Piperacillin; Tazobactam; Tobramycin; Vancomycin | 2008 |
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2008 |
Antimicrobial use among patients receiving palliative care consultation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Decision Making; Drug Utilization; Female; Humans; Infections; Male; Michigan; Middle Aged; Palliative Care; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Retrospective Studies; Vancomycin | 2010 |
An unusual case of septic shock in a geriatric patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Antidiuretic Agents; Capnocytophaga; Female; Fluid Therapy; Gram-Negative Bacterial Infections; Humans; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Risk Factors; Shock, Septic; Tazobactam; Vancomycin; Vasopressins | 2010 |
Antithymocyte globulin-induced acute lung injury during transplantation for aplastic anemia.
Topics: Acute Lung Injury; Anemia, Aplastic; Animals; Anti-Bacterial Agents; Antilymphocyte Serum; Bacterial Infections; Bone Marrow Transplantation; Child; Cyclophosphamide; Horses; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Transplantation Conditioning; Vancomycin; Vidarabine | 2011 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
A vesiculobullous eruption in a hospitalized patient. Diagnosis: Drug-induced linear IgA bullous dermatosis (LAD) with eosinophils.
Topics: Aged; Anti-Bacterial Agents; Drug Eruptions; Eosinophils; Female; Humans; Immunoglobulin A; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Skin Diseases, Vesiculobullous; Vancomycin | 2011 |
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; Hospitals, Veterans; Humans; Imipenem; Meropenem; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins; United States; Vancomycin | 2012 |
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin | 2012 |
Pustular eruption in the ICU.
Topics: Acute Generalized Exanthematous Pustulosis; Amputation, Surgical; Anti-Bacterial Agents; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Humans; Intensive Care Units; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Vancomycin | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Skin Diseases, Bacterial; Skin Diseases, Infectious; Sulbactam; Treatment Outcome; Vancomycin | 2013 |
Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Drug Combinations; Drug Stability; Humans; Infusions, Intravenous; Isotonic Solutions; Nephelometry and Turbidimetry; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Vancomycin | 2013 |
Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin-tazobactam as compared with cefepime.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Diabetes Complications; Drug Therapy, Combination; Humans; Incidence; Middle Aged; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2014 |
Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin | 2014 |
Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2014 |
Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Anti-Bacterial Agents; Drug Synergism; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Clostridium; Clostridium Infections; Cytomegalovirus Infections; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2014 |
An optimized mouse thigh infection model for enterococci and its impact on antimicrobial pharmacodynamics.
Topics: Ampicillin; Anaerobiosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Mice, Inbred ICR; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Vancomycin | 2015 |
Antibiotics "just-in-case" in a patient with aspiration pneumonitis.
Topics: Anti-Bacterial Agents; Cerebral Palsy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Epilepsy, Tonic-Clonic; Fatal Outcome; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Radiography; Vancomycin | 2015 |
Performance of the Baxter Infusor LV10 under hyperbaric conditions.
Topics: Anti-Bacterial Agents; Ceftriaxone; Dopamine; Elastomers; Hyperbaric Oxygenation; Infusion Pumps; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Temperature; Time Factors; Vancomycin | 2015 |
Broncholithiasis presenting as bronchiectasis and recurrent pneumonias.
Topics: Anti-Bacterial Agents; Bronchial Diseases; Bronchiectasis; Bronchoalveolar Lavage; Chest Pain; Dyspnea; Female; Fever; Humans; Lithiasis; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Recurrence; Treatment Outcome; Vancomycin | 2015 |
Drug-induced immune-mediated thrombocytopenia in the intensive care unit.
Topics: Device Removal; Female; Humans; Immunoglobulin G; Intensive Care Units; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Purpura, Thrombocytopenic, Idiopathic; Vancomycin | 2015 |
A 13-Year-Old Boy with Pancytopenia and a Sacrococcygeal Abscess.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Glucocorticoids; Humans; Male; Pancytopenia; Penicillanic Acid; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Sacrococcygeal Region; Tazobactam; Vancomycin | 2015 |
Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Regression Analysis; Risk Factors; Tazobactam; Vancomycin | 2015 |
Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Insufficiency; Retrospective Studies; Risk Assessment; Vancomycin | 2016 |
A Common But Not so Typical Elevated Anion Gap.
Topics: Acetone; Acidosis; Adult; Anti-Bacterial Agents; Blood Glucose; Confusion; Diabetes Complications; Fever; Fluid Therapy; Humans; Leg Injuries; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Sodium Bicarbonate; Staphylococcal Infections; Vancomycin | 2016 |
Impact of an Antimicrobial Stewardship Program on Patient Safety in Veterans Prescribed Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Drug Therapy, Combination; Female; Hospital Departments; Humans; Interrupted Time Series Analysis; Male; Middle Aged; Patient Safety; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Veterans | 2016 |
Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.
Topics: Anti-Bacterial Agents; Chemical Precipitation; Drug Compounding; Drug Incompatibility; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sodium Chloride; Time Factors; Vancomycin | 2016 |
Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins; Treatment Outcome; Vancomycin | 2017 |
Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Arkansas; Cefepime; Cephalosporins; Critical Illness; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Michigan; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2016 |
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactams; Blood Culture; Clostridiales; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Surgical Wound Infection; Vancomycin | 2016 |
Emphysematous pyelonephritis in a renal allograft.
Topics: Anti-Bacterial Agents; Comorbidity; Diabetes Mellitus; Diabetic Ketoacidosis; Drug Therapy, Combination; Emphysema; Humans; Hypertension; Kidney Transplantation; Male; Middle Aged; Norepinephrine; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Pyelonephritis; Tomography, X-Ray Computed; Transplantation, Homologous; Vancomycin | 2017 |
Antimicrobial Monotherapy versus Combination Therapy for the Treatment of Complicated Intra-Abdominal Infections.
Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Intraabdominal Infections; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Sepsis; Vancomycin | 2016 |
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Retrospective Studies; Risk; Severity of Illness Index; Vancomycin | 2017 |
Spontaneous Nasal Septal Abscess Presenting as a Soft Tissue Mass in a Child.
Topics: Abscess; Amoxicillin; Anti-Bacterial Agents; Child; Emergency Service, Hospital; Epistaxis; Fever; Humans; Magnetic Resonance Imaging; Male; Methicillin-Resistant Staphylococcus aureus; Nasal Septum; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rupture, Spontaneous; Tomography, X-Ray Computed; Vancomycin | 2017 |
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; Enterobacter cloacae; Female; Humans; Imipenem; Kidney Failure, Chronic; Kidney Transplantation; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Respiratory Insufficiency; Vancomycin | 2017 |
Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Cohort Studies; Creatinine; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tertiary Care Centers; Time Factors; Vancomycin | 2017 |
Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Treatment Outcome; Vancomycin | 2017 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2017 |
Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; Vancomycin; Young Adult | 2017 |
Between fire and ice: refractory hypothermia and warmth-induced pain in inherited erythromelalgia.
Topics: Anti-Bacterial Agents; Child; Cold Temperature; Erythromelalgia; Female; Furosemide; Hot Temperature; Humans; Hypothermia; Mutation, Missense; NAV1.7 Voltage-Gated Sodium Channel; Pain; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polyethylene Glycols; Rewarming; Skin Diseases, Vesiculobullous; Sodium Potassium Chloride Symporter Inhibitors; Surface-Active Agents; Thyroxine; Treatment Outcome; Vancomycin | 2017 |
Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Hospitals, Military; Humans; Incidence; Logistic Models; Male; Middle Aged; Military Personnel; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Tertiary Care Centers; Vancomycin | 2017 |
Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Critical Illness; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Logistic Models; Male; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2017 |
Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Databases, Factual; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Length of Stay; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Assessment; United States; Vancomycin | 2017 |
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin | 2017 |
Peculiar purulence: Hypervirulent Klebsiella pneumoniae causing pyomyositis.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Abscess; Male; Middle Aged; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyomyositis; Vancomycin | 2017 |
Pediatric acute kidney injury induced by concomitant vancomycin and piperacillin-tazobactam.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Databases, Factual; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Infant; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Saudi Arabia; Vancomycin | 2018 |
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
Topics: Anti-Bacterial Agents; Bursitis; Debridement; Elbow Injuries; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Olecranon Process; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propionibacterium acnes; Soft Tissue Injuries; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2018 |
Bullous eyelid.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Diagnosis, Differential; Eyelid Diseases; Eyelids; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 2018 |
Role Of Conservative Management In Emphysematous Gastritis.
Topics: Adult; Anti-Bacterial Agents; Conservative Treatment; Emphysema; Female; Fluid Therapy; Gastric Mucosa; Gastritis; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tomography, X-Ray Computed; Vancomycin | 2018 |
Nephrotoxicity of piperacillin/tazobactam combined with vancomycin: should it be a concern?
Topics: Acute Kidney Injury; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney; Logistic Models; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Thienamycins; Vancomycin | 2018 |
The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Cefmetazole; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Period; Male; Middle Aged; Pancreaticoduodenectomy; Penicillanic Acid; Piperacillin; Retrospective Studies; Surgical Wound Infection; Tazobactam; Time Factors; Vancomycin | 2018 |
Pyopericardium progressing to tamponade in a patient with immune thrombocytopenia.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cardiac Tamponade; Disease Progression; Drainage; Female; Humans; Penicillanic Acid; Pericardial Effusion; Pericarditis, Constrictive; Piperacillin; Piperacillin, Tazobactam Drug Combination; Purpura, Thrombocytopenic, Idiopathic; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Vancomycin | 2018 |
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 2018 |
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam-Reply.
Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 2018 |
Vancomycin/Piperacillin-tazobactam Nephrotoxicity in the Critically Ill.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Critical Illness; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Vancomycin | 2020 |
Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Retrospective Studies; Vancomycin | 2020 |
Tolerance and microbiological efficacy of cefepime or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cohort Studies; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Short Versus Extended Duration Vancomycin and Piperacillin/Tazobactam and the Incidence of Acute Kidney Injury in Noncritically Ill Patients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2021 |
Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Teicoplanin; Vancomycin | 2021 |
Risk factors for acute kidney injury in vancomycin and piperacillin/tazobactam combination therapy: A retrospective study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin | 2021 |
Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Teicoplanin; Vancomycin | 2021 |
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bayes Theorem; Cefepime; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Retrospective Studies; Vancomycin | 2021 |
Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Cefepime; Cohort Studies; Critical Illness; Drug Therapy, Combination; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Vancomycin | 2022 |
The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW).
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Vancomycin | 2022 |
Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Biomarkers; Cefepime; Creatinine; Critical Illness; Cystatin C; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Renal Dialysis; Retrospective Studies; Vancomycin | 2022 |
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aorta; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thrombocytopenia; Vancomycin | 2022 |
A ray of hope in the discord: is adding piperacillin-tazobactam to vancomycin truly more nephrotoxic?
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2022 |
Simultaneous infusion of two incompatible antibiotics: Impact of the choice of infusion device and concomitant simulated fluid volume support on the particulate load and the drug mass flow rates.
Topics: Anti-Bacterial Agents; Drug Incompatibility; Infusions, Intravenous; Infusions, Parenteral; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2022 |
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin; Young Adult | 2023 |
A case of Robinsoniella peoriensis bacteremia during using piperacillin-tazobactam.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Female; Fever; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2023 |
Iohexol-Measured Glomerular Filtration Rate and Urinary Biomarker Changes between Vancomycin and Vancomycin Plus Piperacillin-Tazobactam in a Translational Rat Model.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biomarkers; Drug Therapy, Combination; Glomerular Filtration Rate; Iohexol; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Retrospective Studies; Vancomycin | 2023 |